Results 281 to 290 of about 803,924 (342)
Some of the next articles are maybe not open access.
Is there clinical benefit to routine enzyme testing of patients on statins?
Expert Opinion on Drug Safety, 2011Statin-treated patients undergo frequent laboratory tests. This study evaluated the clinical impact of abnormal liver or muscle enzyme results.This clinical process evaluation study took place in six primary care clinics in Israel. Four hundred and eight patients (average age 63.8 ± 10.9 years) undergoing statin treatment, with at least one enzyme ...
Shlomo Vinker +2 more
openaire +2 more sources
Enzyme-Linked Immunosorbent Urine Pregnancy Tests Clinical Specificity Studies
American Journal of Clinical Pathology, 1987The performance of six recently introduced highly sensitive enzyme-linked immunosorbent (ELISA) urine pregnancy test reagent kits was evaluated for false positive results using 100 male and 100 postmenopausal female urine specimens and the findings were compared with those of a qualitative radioimmunoassay (RIA) procedure.
Mila DeLara, Z. L. Bandi, Irwin Schoen
openaire +3 more sources
Molecular Genetics and Metabolism, 2012
Establishing a simple and effective mutation screening method is one of the most compelling problems with applying genetic diagnosis to clinical use. Because there is no reliable and inexpensive screening system, amplifying by PCR and performing direct sequencing of every coding exon is the gold standard strategy even today.
Ayano Yokoi +4 more
openaire +3 more sources
Establishing a simple and effective mutation screening method is one of the most compelling problems with applying genetic diagnosis to clinical use. Because there is no reliable and inexpensive screening system, amplifying by PCR and performing direct sequencing of every coding exon is the gold standard strategy even today.
Ayano Yokoi +4 more
openaire +3 more sources
Journal of Clinical Virology, 2008
Centers for Disease Control (CDC) guidelines require confirmation of hepatitis C virus (HCV) screening-test-positive sera with a low signal/cut-off (S/CO) ratio by recombinant immunoblot or PCR. The UK Health Protection Agency has suggested that a second enzyme immunoassay (EIA) could be used as an alternative for confirmation in non-immunocompromised ...
Marc Van Ranst +2 more
openaire +3 more sources
Centers for Disease Control (CDC) guidelines require confirmation of hepatitis C virus (HCV) screening-test-positive sera with a low signal/cut-off (S/CO) ratio by recombinant immunoblot or PCR. The UK Health Protection Agency has suggested that a second enzyme immunoassay (EIA) could be used as an alternative for confirmation in non-immunocompromised ...
Marc Van Ranst +2 more
openaire +3 more sources
American Journal of Gastroenterology, 2003
The aim of the present study was to assess the correlation of Triage Micro Clostridium difficile Panel and toxin B cytotoxicity assay with the clinical diagnosis of C. difficile diarrhea.The subjects evaluated were 98 patients with diarrhea for whom stool was submitted for testing for C. difficile.
Christina M. Surawicz +4 more
openaire +3 more sources
The aim of the present study was to assess the correlation of Triage Micro Clostridium difficile Panel and toxin B cytotoxicity assay with the clinical diagnosis of C. difficile diarrhea.The subjects evaluated were 98 patients with diarrhea for whom stool was submitted for testing for C. difficile.
Christina M. Surawicz +4 more
openaire +3 more sources
American Journal of Clinical Pathology, 1983
An assay for circulating immune complexes (CIC) that is adaptable to a routine clinical laboratory is described. This solid phase C1q (SP C1q) enzyme immunoassay (EIA) uses commercially available reagents and is reproducible with CV% of less than 20% in the abnormal range.
Anne L. Vahey +3 more
openaire +4 more sources
An assay for circulating immune complexes (CIC) that is adaptable to a routine clinical laboratory is described. This solid phase C1q (SP C1q) enzyme immunoassay (EIA) uses commercially available reagents and is reproducible with CV% of less than 20% in the abnormal range.
Anne L. Vahey +3 more
openaire +4 more sources
Scandinavian Journal of Gastroenterology, 1986
Ten patients with chronic pancreatitis (with abdominal pain and/or diarrhoea) were treated in a double-blind multiple cross-over trial with Pankreon granules 20 g per day or placebo during three periods of one month each. Pain and bowel habits were recorded.
J Svanvik, Stockbrügger, U Armbrecht
openaire +3 more sources
Ten patients with chronic pancreatitis (with abdominal pain and/or diarrhoea) were treated in a double-blind multiple cross-over trial with Pankreon granules 20 g per day or placebo during three periods of one month each. Pain and bowel habits were recorded.
J Svanvik, Stockbrügger, U Armbrecht
openaire +3 more sources
Cancer Research, 2013 Abstract Many solid human tumors generate an acidic and hypoxic microenvironment as a result of altered metabolic pathways and aberrant tumor vasculature. In certain tumors, the chronic exposure to acidic extracellular conditions has been reported to promote invasiveness and metastatic behaviour.
Heman Chao +4 more
openalex +3 more sources
American Journal of Infection Control, 2013
The impact of a new Clostridium difficile nucleic acid amplification test (NAAT) on antibiotic utilization in patients with suspected C difficile infection was assessed. This single-center, cross-sectional study of 270 patients demonstrated that the use of NAAT decreased antibiotic expenditure by reducing prolonged empiric days of therapy in these ...
Steven W. Johnson +4 more
openaire +3 more sources
The impact of a new Clostridium difficile nucleic acid amplification test (NAAT) on antibiotic utilization in patients with suspected C difficile infection was assessed. This single-center, cross-sectional study of 270 patients demonstrated that the use of NAAT decreased antibiotic expenditure by reducing prolonged empiric days of therapy in these ...
Steven W. Johnson +4 more
openaire +3 more sources
Mayo Clinic Proceedings, 1997
To compare the clinical results with the borreliacidal-antibody test (BAT) and two standard screening serologic tests for Lyme disease (LD)-the indirect immunofluorescence assay (IFA) and the enzyme-linked immunosorbent assay (ELISA).The medical records of patients from an endemic LD area, who had been serologically tested during the summer of 1992 ...
William A. Agger, Kay L. Case
openaire +3 more sources
To compare the clinical results with the borreliacidal-antibody test (BAT) and two standard screening serologic tests for Lyme disease (LD)-the indirect immunofluorescence assay (IFA) and the enzyme-linked immunosorbent assay (ELISA).The medical records of patients from an endemic LD area, who had been serologically tested during the summer of 1992 ...
William A. Agger, Kay L. Case
openaire +3 more sources